[1]
Ravasio, R., Marcellusi, A. and De Nicola, L. 2024. Economic impact of dapagliflozin in the management of chronic kidney disease in Italy: results from a micro-simulation model. Global and Regional Health Technology Assessment. 11, 1 (Dec. 2024), 231–238. DOI:https://doi.org/10.33393/grhta.2024.3309.